Author Archive

R&D Systems Releases a New Interactive Pathways & Processes…

Explore multiple intracellular signaling pathways and biological processes in a new interactive format that allows users to access product information and additional scientific information. Molecules…(PRWeb August 06, 2012)Read the full story at h…




Click here for reuse options!
Copyright 2012 Biotechblog

R&D Systems Releases a New Interactive Pathways & Processes…

Explore multiple intracellular signaling pathways and biological processes in a new interactive format that allows users to access product information and additional scientific information. Molecules…(PRWeb August 06, 2012)Read the full story at h…




Click here for reuse options!
Copyright 2012 Biotechblog

Eclipse Therapeutics Appoints Patrick M. O’Connor, Ph.D. to Scientific…

Patrick M. O’Connor, Ph.D., a leader in the discovery and development of oncology drugs, joins the Scientific Advisory Board of Eclipse Therapeutics, Inc., a San Diego-based biotechnology company…(PRWeb August 06, 2012)Read the full story at ht…




Click here for reuse options!
Copyright 2012 Biotechblog

A2LA Bolsters Social Media Presence with Addition of Twitter

Follow A2LA for relevant organizational news as well as news pertaining to accreditation, quality and standards specific to individual accreditation programs that A2LA offers.(PRWeb August 06, 2012)Read the full story at http://www.prweb.com/release…




Click here for reuse options!
Copyright 2012 Biotechblog

SPIE Honors Service and Career Excellence with Senior Member…

New Senior Members have been recognized by SPIE, the international society for optics and photonics, in honor of their service to the Society and their professional achievements.(PRWeb August 05, 2012)Read the full story at http://www.prweb.com/rele…




Click here for reuse options!
Copyright 2012 Biotechblog

Vanta Bioscience Preclinical Research Facility Achieves Good…

U.S.-owned and operated preclinical Contract Research Organization receives GLP accreditation for its toxicology facility in Chennai, India(PRWeb August 05, 2012)Read the full story at http://www.prweb.com/releases/2012/8/prweb9771593.htm




Click here for reuse options!
Copyright 2012 Biotechblog

Drug Patent Expirations for Jul 31 2012

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

Journal of Commercial Biotechnology

ADVERTISE
HERE

This
newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Simple flat-rate database subscription
plans

Ultimate
Plan
Premium Plan Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe
Plan
comparison
    Site
tour
    Discount
schedule
    Contact






Drug Patent Expirations for July 31 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
ETHYOL Medimmune amifostine 5,424,471 Jul 31,
2012
ETHYOL Medimmune amifostine 5,591,731 Jul 31,
2012

*Drugs may be covered by multiple
patents or regulatory protections. See the DrugPatentWatch
database for complete details.








DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details


DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.






Click here for reuse options!
Copyright 2012 Biotechblog

Like this:


Continue reading

Cyth Systems Releases Circaflex 511 Control System for Smaller,…

Cyth Systems announces the release of the newest member of the rapid deployment control platform family to provide life science customers with a complete prototyping solution with lower cost and…(PRWeb August 05, 2012)Read the full story at http:/…




Click here for reuse options!
Copyright 2012 Biotechblog

Gender Selection Clinic Opens New Office in Oceanside, California

To Celebrate its New Location, HRC Fertility is Offering a Temporary Special Price on IVF Treatments(PRWeb August 05, 2012)Read the full story at http://www.prweb.com/releases/2012/8/prweb9769788.htm




Click here for reuse options!
Copyright 2012 Biotechblog

MyCleaningProducts Gives Spider Repellant a New Face – Organic!

MyCleaningProducts introduced a spider repellant that is non-toxic. With it as organic-based, the company aims to make spider sprays safer for users.(PRWeb August 04, 2012)Read the full story at http://www.prweb.com/releases/2012/8/prweb9762280.htm




Click here for reuse options!
Copyright 2012 Biotechblog

%d bloggers like this: